These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20166801)

  • 1. Paliperidone for irritability in autistic disorder.
    Stigler KA; Erickson CA; Mullett JE; Posey DJ; McDougle CJ
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):75-8. PubMed ID: 20166801
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone for irritability in adolescents and young adults with autistic disorder.
    Stigler KA; Mullett JE; Erickson CA; Posey DJ; McDougle CJ
    Psychopharmacology (Berl); 2012 Sep; 223(2):237-45. PubMed ID: 22549762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paliperidone palmitate in a child with autistic disorder.
    Kowalski JL; Wink LK; Blankenship K; Habenicht CD; Erickson CA; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):491-3. PubMed ID: 22040196
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of clozapine for the treatment of aggression in an adolescent with autistic disorder.
    Lambrey S; Falissard B; Martin-Barrero M; Bonnefoy C; Quilici G; Rosier A; Guillin O
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):79-80. PubMed ID: 20166802
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder.
    Canuso CM; Lindenmayer JP; Kosik-Gonzalez C; Turkoz I; Carothers J; Bossie CA; Schooler NR
    J Clin Psychiatry; 2010 May; 71(5):587-98. PubMed ID: 20492853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paliperidone: An improvement over risperidone?
    Dopheide JA
    Am J Health Syst Pharm; 2008 Mar; 65(5):401. PubMed ID: 18281730
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine in the treatment of aggression in an adolescent with autistic disorder.
    Chen NC; Bedair HS; McKay B; Bowers MB; Mazure C
    J Clin Psychiatry; 2001 Jun; 62(6):479-80. PubMed ID: 11465533
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW; Chung YC; Lee YH; Lee JH; Kim SY; Bae KY; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2012 Sep; 27(5):267-74. PubMed ID: 22809972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
    J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
    Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
    Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
    Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of paliperidone in a clozapine-resistant schizophrenic patient.
    Hsieh TH; Liu CT
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E36. PubMed ID: 23686056
    [No Abstract]   [Full Text] [Related]  

  • 16. Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia.
    Chung TS; Lung FW
    J Clin Psychopharmacol; 2012 Jun; 32(3):394-7. PubMed ID: 22544010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
    Varni JW; Handen BL; Corey-Lisle PK; Guo Z; Manos G; Ammerman DK; Marcus RN; Owen R; McQuade RD; Carson WH; Mathew S; Mankoski R
    Clin Ther; 2012 Apr; 34(4):980-92. PubMed ID: 22444782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia.
    Yang DS; Seong SJ; Yoon YR; Lim MS; Kwak KH; Lee SJ
    J Psychopharmacol; 2014 Apr; 28(4):341-8. PubMed ID: 24346811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.